Yingnan Chen

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...
- Patent number 12,060,433
- Issue date Aug 13, 2024
- Incyte Corporation
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylamide compounds as CDK2 inhibitors
- Patent number 11,919,904
- Issue date Mar 5, 2024
- Incyte Corporation
- Alexander Sokolsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
- Patent number 11,472,791
- Issue date Oct 18, 2022
- Incyte Corporation
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
- Patent number 11,427,567
- Issue date Aug 30, 2022
- Incyte Corporation
- Qinda Ye
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20230024173
- Publication date Jan 26, 2023
- INCYTE CORPORATION
- Qinda Ye
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20210230294
- Publication date Jul 29, 2021
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20210107901
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Yingda Ye
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20210047294
- Publication date Feb 18, 2021
- INCYTE CORPORATION
- Qinda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20210017156
- Publication date Jan 21, 2021
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLAMIDE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20200399273
- Publication date Dec 24, 2020
- INCYTE CORPORATION
- Alexander Sokolsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYCLIN-DEPENDENT KINASE 2 BIOMARKERS AND USES THEREOF
- Publication number 20200316064
- Publication date Oct 8, 2020
- INCYTE CORPORATION
- Min Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Yingnan Chen

Person

Patents Grantslast 30 patents

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...

Sulfonylamide compounds as CDK2 inhibitors

Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors

Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors

Patents Applicationslast 30 patents

IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

BICYCLIC AMINES AS CDK2 INHIBITORS

IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

PYRAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

SULFONYLAMIDE COMPOUNDS AS CDK2 INHIBITORS

CYCLIN-DEPENDENT KINASE 2 BIOMARKERS AND USES THEREOF